FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for SILIQ (brodalumab) submitted by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SILIQ (brodalumab)

Snippet

SUPPL AP for SILIQ (BRODALUMAB)